Dioxolane cytosine nucleosides as anti-hepatitis B agents
暂无分享,去创建一个
M. Chun | C. K. Chu | S. Pai | Migyoung Lee | Yung‐chi Cheng | Y. Zhu | W. Chung
[1] Y. Cheng,et al. Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus , 1995, Antimicrobial agents and chemotherapy.
[2] R. Schinazi,et al. Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[3] Y. Cheng,et al. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). , 1994, Journal of medicinal chemistry.
[4] L W Frick,et al. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.
[5] R. Schinazi,et al. Potent anti-HIV and anti-HBV activities of (−)-L-β-dioxolane-C and (+)-L-β-dioxolane-T and their asymmetric syntheses. , 1992 .
[6] R. Schinazi,et al. Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity. , 1992, Journal of medicinal chemistry.